Research and Development in Biotechnology (Except Nanobiotechnology)
NAICS 541714 · Federal Contracts & Awards
Companies in the Research and Development in Biotechnology (Except Nanobiotechnology) industry (NAICS code 541714) have received $19.01B in federal contracts, grants, and other awards since FY2024, across 2K individual awards tracked through FY2026. The largest funding agency is Department of Health and Human Services ($12.94B). Spending is concentrated in Alabama, South Carolina, California and 47 other states. All figures below come from USAspending.gov award records.
Total Obligations
$19.01B
Total Awards
2K
States
50
Last Updated
Apr 23, 2026
Yearly Spending Trend
$17.82B24
$948.0M25
$243.7M26
Top 50 Awards in Research and Development in Biotechnology (Except Nanobiotechnology)
Largest individual obligations in NAICS 541714.
| Award | Recipient | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|---|
CONT_AWD_HQ014719C0004_9700_-NONE-_-NONE- THIS IS A CONTINUATION CONTRACT FROM HQ014712C0004. THE MISSILE DEFENSE AGENCY (MDA), GROUND-BASED MIDCOURSE DEFENSE (GMD) DEVELOPMENT AND SUSTAINMENT CONTRACT (DSC) PROVIDES FOR… | THE BOEING COMPANY Alabama | Department of Defense Missile Defense Agency | — | HUNTSVILLE, AL-05 | 2024 | $4,391,491,940 |
CONT_AWD_75A50123F61004_7505_75A50123D00005_7505 OT TASK ORDER 4 | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $1,245,801,807 |
CONT_AWD_75A50123F61001_7505_75A50123D00005_7505 EOI::RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING ::EOI ADMINISTRATIVE MODIFICATION REPORTING TERMINATION OF PROJECT AGREEMENT | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $795,000,000 |
CONT_AWD_75A50122C00065_7505_-NONE-_-NONE- EXERCISE OPTION PERIOD 4 AND MODIFY THE NUMBER OF DOSES. CHANGE THE PERIOD OF PERFORMANCE TO MARCH 4, 2026 THROUGH SEPTEMBER 29, 2032. THE TOTAL CONTRACT FUNDED VALUE INCREASED FR… | AMGEN USA INC California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | NEWBURY PARK, CA-26 | 2024 | $773,879,007 |
CONT_AWD_75A50123F61003_7505_75A50123D00005_7505 EOI:EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI DEOBLIGATION OF FUNDS AND PARTIAL DE-SCOPE | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $723,524,000 |
CONT_AWD_75A50118C00019_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND FULLY FUND OPTION CLIN 0023, 0025, AND 0027 AND UPDATE ARTICLE I.1 FEDERAL ACQUISITION REGULATIONS (FAR) (48 CFR CHAPTER 1) CLA… | SIGA TECHNOLOGIES, INC. New York | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | CORVALLIS, OR-04 | 2024 | $596,940,981 |
CONT_AWD_75A50124F61008_7505_75A50123D00005_7505 OT TASK ORDER 8-RAPID PANDEMIC INFLUENZA AND EMERGING INFECTIOUS DISEASE VACCINE DEVELOPMENT AND RESPONSE CAPABILITY | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $418,667,305 |
CONT_AWD_75A50123F33005_7505_75A50120D00016_7505 CLINICAL TRIAL PLANNING AND EXECUTION- COVID NEXT GENERATION VACCINE | ALLUCENT GOVERNMENT SERVICES (US) LLC Texas | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | HOUSTON, TX-29 | 2024 | $370,059,439 |
CONT_AWD_75A50123F33006_7505_75A50120D00017_7505 CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE | ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. Ohio | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | HINCKLEY, OH-07 | 2024 | $330,226,484 |
CONT_AWD_75A50123F33004_7505_75A50120D00018_7505 CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE | TECHNICAL RESOURCES INTERNATIONAL, INC. Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | BETHESDA, MD-08 | 2024 | $317,148,294 |
CONT_AWD_75A50120C00001_7505_-NONE-_-NONE- ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION | PARATEK PHARMACEUTICALS, INC Massachusetts | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | BOSTON, MA-07 | 2024 | $265,316,226 |
CONT_IDV_75A50118D00036_7505 THE PURPOSE OF THIS NO COST MODIFICATION IS TO REVISE ARTICLE V, AGREEMENT ADMINISTRATION B, REPLACE THE GOVERNMENT POINTS OF CONTACT. | GENENTECH INC California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $243,700,587 |
CONT_AWD_75A50122C00047_7505_-NONE-_-NONE- CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL - ADD 52.204-14 CLAUSE TO THE CONTRACT | EMERGENT BIODEFENSE OPERATIONS LANSING LLC Massachusetts | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | DURHAM, NC-04 | 2024 | $211,409,788 |
CONT_AWD_75A50122C00061_7505_-NONE-_-NONE- PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES - TRANSFER GFP TO MAPP CONTACT 21C, EXTEND POP FOR CLIN 0001 & 0006 | MAPP BIOPHARMACEUTICAL, INC. California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-51 | 2024 | $184,786,391 |
CONT_AWD_75A50123F61005_7505_75A50123D00005_7505 THE PURPOSE OF THIS MODIFICATION IS TO: 1. CHANGE THE APPROVING OFFICIAL. | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2026 | $161,082,263 |
CONT_AWD_75A50119C00055_7505_-NONE-_-NONE- ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. | ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) District of Columbia | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | WASHINGTON, DC-98 | 2024 | $147,062,009 |
CONT_AWD_75A50122C00028_7505_-NONE-_-NONE- CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA - EXERCISE OPTION 3 | TRUSTEES OF BOSTON UNIVERSITY Massachusetts | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | BOSTON, MA-07 | 2024 | $140,000,000 |
CONT_AWD_75A50123F61002_7505_75A50123D00005_7505 OT TASK ORDER 2 | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $120,250,000 |
CONT_AWD_75A50123C00037_7505_-NONE-_-NONE- THE PURPOSE OF THIS NO-COST MODIFICATION IS TO UPDATE SEVERAL ARTICLES. | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | GAITHERSBURG, MD-06 | 2024 | $118,563,679 |
CONT_AWD_75A50124C00001_7505_-NONE-_-NONE- BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC CAN… | PPD DEVELOPMENT LP North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | WILMINGTON, NC-07 | 2024 | $117,399,278 |
CONT_AWD_47QFWA20C0012_4732_-NONE-_-NONE- MIGRATED ID07200010 59MDW SCIENCE TECHNOLOGY START | ABSS SOLUTIONS INC Maryland | General Services Administration Federal Acquisition Service | — | LACKLAND AFB, TX-23 | 2024 | $115,960,619 |
CONT_AWD_75A50122C00076_7505_-NONE-_-NONE- TRANSFER PROPERTY TO HHSO100201600021C. | MAPP BIOPHARMACEUTICAL, INC. California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-50 | 2024 | $110,877,385 |
CONT_AWD_75A50119C00007_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLES I.1 FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES, 52.204-14 SERVICES CONTRACT REPORTING REQUIREMENTS. | VENATORX PHARMACEUTICALS INC Pennsylvania | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | DOWNINGTOWN, PA-06 | 2024 | $107,189,039 |
CONT_AWD_75A50122C00031_7505_-NONE-_-NONE- SUPPLEMENTAL FUNDING FOR CLIN 001 AND REVISED THE STATEMENT OF WORK. | CROSSJECT SA | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $104,152,986 |
CONT_AWD_75A50123C00056_7505_-NONE-_-NONE- DEOBLIGATE FUNDS FROM CLIN 0006/OPTION 5 PERTAINING TO RNA DEVELOPMENT RELATED EFFORTS; EXTEND POP FOR CLIN 0006 UNTIL FEBRUARY 28, 2027; UPDATE WORK ON SOW FOR CLIN 0001 AND CLIN… | MODEX THERAPEUTICS, INC Massachusetts | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | NATICK, MA-05 | 2024 | $103,516,903 |
CONT_AWD_75A50124F61006_7505_75A50123D00005_7505 MODIFICATION UNDER RRPV OTA WITH ATI TO ADDRESS FUNDING GAPS IN INITIAL TASK ORDER. | ADVANCED TECHNOLOGY INTERNATIONAL South Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUMMERVILLE, SC-01 | 2024 | $100,000,000 |
CONT_AWD_75A50123C00059_7505_-NONE-_-NONE- BARDA OTHER TRANSACTION PRIZE VEHICLE | LUMINARY LABS LLC New York | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | NEW YORK, NY-10 | 2024 | $100,000,000 |
CONT_AWD_N0001924C0061_9700_-NONE-_-NONE- ADMIN UPDATES TO SECTION F AND SECTION J | L3 TECHNOLOGIES, INC. Utah | Department of Defense Department of the Navy | — | SALT LAKE CITY, UT-02 | 2024 | $97,614,155 |
CONT_AWD_75A50121C00077_7505_-NONE-_-NONE- THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACC… | INTERNATIONAL AIDS VACCINE INITIATIVE INC. New York | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | NEW YORK, NY-10 | 2024 | $95,592,504 |
CONT_AWD_75A50123C00010_7505_-NONE-_-NONE- THE PURPOSE OF THIS NO COST MODIFICATION IS TO ADD AN AUDIT OF REITHERA SRL TO THE SCOPE OF CLIN 0005 AS FOLLOWS: 1. CLIN 0005 (OPTION 4) IS HEREBY AMENDED AS FOLLOWS: A. THE STAT… | ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) District of Columbia | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | WASHINGTON, DC-98 | 2024 | $88,424,180 |
CONT_AWD_75A50123C00049_7505_-NONE-_-NONE- DEVELOPMENT OF A BURN WOUND IMAGING TECHNOLOGY DEVICE | SPECTRAL MD, INC. Texas | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | DALLAS, TX-30 | 2024 | $86,574,404 |
CONT_AWD_75N93022F00002_7529_75N93021D00035_7529 "COVID 19" COMPLETION OF ACTIV 2 STUDY | PPD DEVELOPMENT LP North Carolina | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2025 | $82,531,927 |
CONT_AWD_75N93019C00070_7529_-NONE-_-NONE- IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) | SEATTLE CHILDREN'S HOSPITAL Washington | Department of Health and Human Services National Institutes of Health | — | SEATTLE, WA-07 | 2024 | $81,792,814 |
CONT_AWD_75A50120C00177_7505_-NONE-_-NONE- EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS. | VEDANTA BIOSCIENCES, INC. Massachusetts | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | BOSTON, MA-08 | 2024 | $79,146,088 |
CONT_AWD_75N93019C00053_7529_-NONE-_-NONE- 19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE. | DUKE UNIVERSITY North Carolina | Department of Health and Human Services National Institutes of Health | — | DURHAM, NC-04 | 2024 | $77,435,931 |
CONT_AWD_75A50121C00024_7505_-NONE-_-NONE- OTA - PANDEMIC PREPAREDNESS AND RESPONSE: ESTABLISHING A PLATFORM FOR DIAGNOSIS AND SURVEILLANCE OF EMERGING THREATS | CEPHEID California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SUNNYVALE, CA-17 | 2024 | $74,983,757 |
CONT_AWD_75N93024F00001_7529_75N93021D00035_7529 NIAID CLINICAL SITE MONITORING (NCSM) | PPD DEVELOPMENT LP North Carolina | Department of Health and Human Services National Institutes of Health | — | WILMINGTON, NC-07 | 2024 | $73,196,564 |
CONT_AWD_75A50122C00080_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLES I.1 FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES, 52.204-14 SERVICES CONTRACT REPORTING REQUIREMENTS. | VENATORX PHARMACEUTICALS INC Pennsylvania | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | MALVERN, PA-06 | 2024 | $72,141,707 |
CONT_AWD_75A50122C00081_7505_-NONE-_-NONE- VIR BIOTECHNOLOGY - OTA FOR PRE-EXPOSURE PROPHYLACTIC MONOCLONAL ANTIBODIES FOR THE PREVENTION OF INFLUENZA ILLNESS AND MEDICAL COUNTERMEASURES FOR OTHER EMERGING PATHOGENS OF PAN… | VIR BIOTECHNOLOGY, INC. California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN FRANCISCO, CA-11 | 2024 | $65,867,804 |
CONT_AWD_75A50119C00054_7505_-NONE-_-NONE- EOI::PRESIDENTIAL COST SAVINGS INITIATIVE (FEBRUARY 26, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE | BIOFACTURA INC Maryland | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | FREDERICK, MD-06 | 2024 | $65,806,222 |
CONT_AWD_75A50122C00046_7505_-NONE-_-NONE- EXERCISE CLIN 0004 OPTION PERIOD 1 AND REVISE THE POP TO 3/23/26-11/15/29. REVISE THE TASKS IN CLIN 0006 OF THE SOW. | ABBOTT LABORATORIES Illinois | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | NORTH CHICAGO, IL-10 | 2024 | $65,469,511 |
CONT_AWD_75A50122C00007_7505_-NONE-_-NONE- PROCURE A PANDEMIC INFLUENZA VACCINE (PANDFLU) AND A QUADRIVALENT SEASONAL INFLUENZA VACCINE (QSFLU) | ARCTURUS THERAPEUTICS, INC. California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-50 | 2024 | $63,239,785 |
CONT_AWD_75A50118C00013_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FOR CLIN0006 OPTION 2C THROUGH MAY 31, 2025, AT NO ADDITIONAL COST TO THE GOVERNMENT DUE TO THE 2-MONTH DEL… | SELUX DIAGNOSTICS, INC. Massachusetts | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | CHARLESTOWN, MA-07 | 2024 | $62,626,468 |
CONT_AWD_75A50118C00012_7505_-NONE-_-NONE- JANSSEN - TPOM OT AGREEMENT | JANSSEN RESEARCH & DEVELOPMENT, LLC New Jersey | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | RARITAN, NJ-07 | 2024 | $58,763,098 |
CONT_AWD_75A50125C00017_7505_-NONE-_-NONE- DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA | CIDARA THERAPEUTICS INC California | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-51 | 2025 | $58,051,983 |
CONT_AWD_75N93019C00071_7529_-NONE-_-NONE- IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) | PRESIDENT AND FELLOWS OF HARVARD COLLEGE Massachusetts | Department of Health and Human Services National Institutes of Health | — | BOSTON, MA-07 | 2024 | $57,273,778 |
CONT_AWD_75N93024F00001_7529_75N93021D00038_7529 NIAID/DAIDS REGULATORY SUPPORT CENTER | TECHNICAL RESOURCES INTERNATIONAL, INC. Maryland | Department of Health and Human Services National Institutes of Health | — | ROCKVILLE, MD-08 | 2024 | $56,583,915 |
CONT_AWD_75A50120C00169_7505_-NONE-_-NONE- THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO: 1.SUPPLEMENTALLY FUND CLIN 0003. 2.UPDATE KEY PERSONNEL. 3.EXTEND PERIOD OF PERFORMANCE FOR CLINS 0002 AND 0003 TO END 12/31/2026. | LOCUS BIOSCIENCES INC North Carolina | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | MORRISVILLE, NC-02 | 2024 | $55,885,104 |
CONT_AWD_75A50119C00022_7505_-NONE-_-NONE- THE PURPOSE OF THIS MODIFICATION IS TO CORRECT THE PERIOD OF PERFORMANCE FOR CLIN0004/OPTION 3 TO APRIL 30, 2026, TO ALIGN WITH IPP. | PUBLIC HEALTH VACCINES LLC Massachusetts | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | CAMBRIDGE, MA-07 | 2024 | $55,547,654 |
CONT_AWD_N6600119C4022_9700_-NONE-_-NONE- DARPA BTO PROGRAM - WMD ECHO DETECTOR MOD FOR INCREMENTAL FUNDING AND CDRL REVISION | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI New York | Department of Defense Department of the Navy | — | NEW YORK, NY-13 | 2024 | $47,162,783 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Top Funding Agencies
View All→12345678910
Department of Health and Human Services$12.94B
Department of Defense$5.81B
General Services Administration$117.3M
Department of Veterans Affairs$82.7M
National Aeronautics and Space Administration$30.6M
Department of the Interior$18.0M
Department of Agriculture$9.6M
Department of State$1.5M
Environmental Protection Agency$865K
Department of Commerce$862K
Top Recipients
View All→12345678910
THE BOEING COMPANY$4.39B
ADVANCED TECHNOLOGY INTERNATIONAL$3.58B
AMGEN USA INC$774.7M
SIGA TECHNOLOGIES, INC.$596.9M
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.$393.9M
TECHNICAL RESOURCES INTERNATIONAL, INC.$386.2M
ALLUCENT GOVERNMENT SERVICES (US) LLC$384.2M
MAPP BIOPHARMACEUTICAL, INC.$352.5M
PPD DEVELOPMENT LP$346.4M
PARATEK PHARMACEUTICALS, INC$265.3M
Spending by State
| State | Funding | Awards |
|---|---|---|
| Alabama | $4.42B | 36 |
| South Carolina | $3.59B | 17 |
| California | $2.07B | 289 |
| Maryland | $1.30B | 375 |
| Massachusetts | $1.25B | 126 |
| North Carolina | $952.1M | 109 |
| Texas | $704.1M | 80 |
| Oregon | $609.2M | 17 |
| Ohio | $542.2M | 50 |
| New York | $421.3M | 87 |
| Pennsylvania | $393.9M | 76 |
| District of Columbia | $375.3M | 30 |
| Illinois | $221.7M | 67 |
| Utah | $192.5M | 35 |
| New Jersey | $183.4M | 49 |
| Washington | $177.5M | 37 |
| Virginia | $164.1M | 64 |
| Colorado | $107.6M | 43 |
| New Mexico | $65.5M | 21 |
| Montana | $64.7M | 5 |
| Wisconsin | $54.0M | 76 |
| Hawaii | $51.3M | 12 |
| New Hampshire | $47.1M | 8 |
| Michigan | $42.0M | 16 |
| Florida | $40.8M | 22 |
| Georgia | $40.7M | 41 |
| Missouri | $31.5M | 19 |
| Oklahoma | $23.9M | 21 |
| Louisiana | $22.6M | 8 |
| Delaware | $21.5M | 11 |
| Connecticut | $19.4M | 10 |
| Kentucky | $17.5M | 17 |
| Arkansas | $15.3M | 3 |
| Indiana | $13.6M | 22 |
| Tennessee | $13.4M | 25 |
| Kansas | $12.3M | 2 |
| Mississippi | $10.1M | 14 |
| Minnesota | $9.8M | 12 |
| Arizona | $9.0M | 22 |
| Maine | $6.8M | 8 |
| Iowa | $6.1M | 23 |
| Vermont | $3.3M | 2 |
| Nevada | $2.2M | 3 |
| Idaho | $2.2M | 6 |
| West Virginia | $805K | 6 |
| Puerto Rico | $318K | 1 |
| Rhode Island | $314K | 8 |
| North Dakota | $144K | 4 |
| Wyoming | $89K | 1 |
| Nebraska | $33K | 1 |
Source: USAspending.gov · All Industries